CS Paper Radar

Detecting Glaucoma Across Multi-ethnic Myopic and Non-Myopic Populations Using an Uncertainty-Aware Vision Transformer: A Multicentre Model Development and Validation Study

Raghavan Lavanya, Yangqin Feng, Ten Cheer Quek, Quan V. Hoang, Linda Yi-Chieh Poon, Jost B. Jonas, Ya Xing Wang, Vinay Nangia, Jin Wook Jeoung, Sehie Park, SoYeon Kim, Benjamin Y Xu, Sreenidhi Iyengar Munimadugu, Paul Mitchell, Gerald Liew, Yanin Suwan, Jirayu Hong-amata, Sahil Thakur, Monisha E Nongipur, Tina Wong, Rahat Husain, Ng Si Rui, Yamon Syn, Phey Feng Lo, Nicholas Tan Yi Qiang, Shaista Hussain, Xiaofeng Lei, Zhi Da Soh, Marco Yu, Haslina Hamzah, Zizhou Wang, Yan Wang, Liangli Zhen, Xinxing Xu, Tien-Yin Wong, Tin Aung, Rachel S Chong, Yong Liu, Ching-Yu Cheng

cs.CV cs.AI ·submitted 2026-09-24 11:51 UTC · v2

Abstract

Background: Artificial intelligence (AI)-based glaucoma detection from colour fundus photographs (CFP) offers scalable screening, but performance may decline on external datasets because of differences in ground-truth definitions, populations, and coexisting conditions such as high myopia (HM). We developed and validated a Vision Transformer-based deep learning (DL) model for glaucoma detection across multi-ethnic cohorts with and without HM. Methods: A ViT-B/16 model with predictive uncertainty estimation was developed using 56,483 CFPs (57.1% with myopia; 14.4% with HM). Glaucoma labels were standardised using clinical, imaging, and perimetry data. The model was validated on 16 independent datasets across three continents, including four datasets with explicit HM labels. Findings: Internal AUROC was 98.7% (95% CI 98.2-99.1%), with sensitivity 94.5% and specificity 97.3%. Across 16 external datasets from eight countries, AUROCs ranged from 86.4% to 99.6%. In HM eyes, internal AUROC was 97.8% (95% CI 96.1-99.2%), with sensitivity 94.8% and specificity 93.7%. External HM AUROCs were 86.5% in the Beijing Eye Study and 93.3%, 91.8%, and 85.5% in hospital-based datasets from Taiwan, Thailand, and South Korea. In an exploratory HM clinical evaluation, the model had higher CFP-only diagnostic accuracy than ophthalmologists and trained graders (92.0% vs 70.0%; p=0.008) and performed comparably to glaucoma specialists using full clinical information. Interpretation: The model showed robust glaucoma detection across myopic and non-myopic multi-ethnic populations and may support AI-assisted screening in settings with high HM prevalence.

Closest papers

Nearest neighbours by meaning across the whole index.

Interpretable AI plus Handheld, Portable Retinal Photographs: A Low-Cost Glaucoma Screening Solution for West Africa

cs.CV cs.AI ·2026-09-22 ·Charis Y. N. Chiang, Tarela Sarimiye, Adeyinka Ashaye, Martin Buist, Michael A. Hauser +2 more
similarity 0.71
Abstract · 31 pages, 2 Tables, 5 Figures, 1 Supplementary Material

Purpose: To develop and evaluate an interpretable artificial intelligence (AI) framework for glaucoma screening from low-cost portable, handheld retinal fundus photographs in a West African population and to compare its performance with clinical tabletop fundus imaging. Methods: We used data from a community-based study of 681 participants (1,362 eyes) in Nigeria, comprising 414 glaucoma, 478 glaucoma suspect, and 470 non-glaucoma eyes. Fundus photographs were acquired using the low-cost handheld, portable Volk Viva retinal camera and the Canon CR-2-AF tabletop camera. We fine-tuned component models separately to each device to perform vessel segmentation, cup and disc boundary segmentation, and feature extraction to detect optic nerve head features. A final classification model combined these components to classify scans as glaucoma, glaucoma suspect or non-glaucoma. Feature-weight analysis and Gradient-weighted Class Activation Mapping were used for interpretation. Results: The models performed well on both Volk Viva and Canon CR-2-AF images: Vessel segmentation: 0.98 Dice Coefficient (DC) (Volk) and 0.94 DC (Canon); Cup and disc segmentation: 0.95 DC (Volk) and 0.96 DC (Canon); Optic nerve head feature detection: area under the receiver operating characteristic curve (AUCs) of 0.83$\pm$0.03 (Volk) and 0.87$\pm$0.04 (Canon); Classification model: AUCs of 0.85$\pm$0.01 (Volk) and 0.93$\pm$0.01 (Canon). Reports for each image, present model decision confidence scores and decision-rationale visualizations to support clinical interpretation. Conclusions: Volk Viva results were reasonably comparable to Canon CR-2-AF in the component models and not far behind in classification. This shows that interpretable AI combined with low-cost, portable imaging may enhance community-level glaucoma screening, especially in settings with limited specialist access and resources.

0.32

Evidential Deep Learning with conditional entropy for glaucoma detection

cs.CV cs.LG ·2026-11-10 ·Hai Siong Tan, Kuancheng Wang
published similarity 0.70
Abstract · 15 pages, 4 figures. To appear in TAAI 2026

We propose a novel conditional entropy function as a basis for quantifying predictive uncertainty in Evidential Deep Learning (EDL) for glaucoma detection from retinal fundus images. Using the EyePACS-AIROGS-light-V2 and RIM-ONE-DL datasets for validation, we found that our proposed EDL model regularized by conditional entropy function produced uncertainty estimates with substantially lower calibration errors than Deep Ensembles, MC Dropout, post-hoc calibration and the conventional EDL framework based on Dempster uncertainty. To further probe our models' interpretability, we analyzed Grad-CAM heatmaps using a focus index representing spatial concentration. Compared with the other uncertainty quantification methods, EDL models exhibited greater separation between the index distributions of correctly and incorrectly classified fundus images. In particular, false negatives were associated with localized Grad-CAM activations that were displaced from the optic disc, consistent with its established clinical importance in glaucoma assessment. Overall, our findings suggest that our proposed EDL framework for glaucoma detection provides not only enhanced uncertainty calibration but also admits a more physiologically consistent interpretability.

0.33

Beyond Accuracy: Benchmarking Uncertainty Quantification in Retinal Disease Screening

eess.IV ·2026-11-17 ·Mahvash Jebeli, Mohammad Eslami, Nazlee Zebardast, Lucia Sobrin, Tobias Elze
benchmarkdataset similarity 0.69
Abstract

Reliable uncertainty quantification (UQ) is essential for evaluating retinal AI systems beyond classification accuracy, yet it remains unclear whether existing UQ strategies generalize across diseases, model architectures, and reliability criteria. We introduce a large-scale, multi-disease benchmark comprising over $242,000$ fundus photographs from $32$ datasets covering diabetic retinopathy, age-related macular degeneration, and glaucoma. We evaluate six representative UQ strategies across three Vision Transformer configurations, assessing discrimination, probabilistic calibration, selective prediction, and conformal prediction-set coverage. Our findings reveal no universally superior model or UQ strategy: methods that improve reliability in one disease or architecture may underperform in another, while improvements in discrimination, calibration, and selective prediction do not necessarily align. Notably, computationally intensive methods do not consistently outperform simple confidence scores, and domain-specific foundation models and calibration-oriented loss functions do not guarantee greater reliability. In contrast, conformal prediction provides a complementary framework for achieving near-nominal marginal prediction-set coverage across diverse settings, subject to its statistical assumptions. These findings challenge universal UQ recommendations and highlight the need for disease-specific, model-specific, and multidimensional reliability evaluation before clinical deployment. We release standardized dataset splits, trained checkpoints, evaluation code, and an interactive research demonstration to support reproducible benchmarking.

0.06

Auto-GlaKG: Automated Biomarker Reasoning for Explainable Glaucoma Detection

cs.CV cs.AI ·2026-11-08 ·Cheng Huang, Zeyu Han, Yian Hu, Yaopeng Ding, Jingxi Qiu +1 more
similarity 0.68
Abstract

Interpretable glaucoma detection requires a transparent connection between fundus images, clinically meaningful biomarkers, and diagnostic predictions. Knowledge graph (KG) reasoning provides this structure, but performance measured using annotated biomarkers does not establish performance when only images are available. We present Auto-GlaKG, an automated framework that combines image-based biomarker prediction with fixed clinical-prior rules. A ResNet50 network predicts the cup-to-disc ratio (CDR) and six morphological signs using biomarker supervision, and a KG reasoner aggregates their signed rule contributions into a glaucoma score. On 689 fundus images evaluated using stratified, group-aware five-fold cross-validation, Auto-GlaKG achieves a pooled area under the receiver operating characteristic curve (AUC) of 0.951 (95\% confidence interval: 0.931--0.969), with sensitivity of 0.970 and specificity of 0.779. The matched image classifier also achieves an AUC of 0.951, while the rule stage adds 0.2~ms per image. Replacing predicted CDR with its annotation increases fold-mean AUC from 0.953 to 0.995. The framework provides an explicit rule-level account of image-based predictions and identifies CDR estimation as a priority for validation using independently measured biomarkers.

0.22

Cross-Dataset Generalization of Glaucoma Detection CNNs: Effects of Operating Threshold, Multi-Source Training, and Color Normalization

eess.IV cs.CV ·2026-11-01 ·Al-Amin Rahman, Saifuddin Ahmed, Resalat Ahmed
similarity 0.66
Abstract · 17 pages, 10 figures, 11 tables

Deep learning models for glaucoma detection are usually tested on images from the same dataset used for training. That says little about how they will work at a new hospital or with a new camera. We fine-tuned five ImageNet-pretrained CNNs (ResNet50, DenseNet121, MobileNetV2, EfficientNet-B0, InceptionV3) with identical settings on one of three public fundus datasets (ACRIMA, ORIGA, RIM-ONE DL). Each was tested on a held-out part of its own dataset and on the other two datasets in full. We used three random seeds and report mean and SD over seeds. Mean in-domain AUC was 0.913 and cross-source AUC was 0.702, a drop of 0.211 (SD 0.030; 95% CI 0.135 to 0.286). After correction for multiple comparisons we found no evidence that any architecture did better, though three seeds give low power. At thresholds set on the source validation data, specificity fell from 0.870 to 0.506 and sensitivity from 0.831 to 0.726. Resetting the threshold on 10% of the target images raised specificity to 0.670 but lowered sensitivity to 0.609, and balanced accuracy rose only from 0.616 to 0.639. Training on two sources together did not help (held-out AUC 0.695 versus 0.702). LAB reference normalization (cross-source AUC 0.755) and strong color augmentation (0.754) gave similar gains, cutting the drop to about 0.16. Ben Graham normalization (0.733) and CLAHE (0.712) helped less, and gray-world (0.696) did not help. The two best methods raised specificity but lowered sensitivity. On G1020, used only for testing, AUC stayed near 0.5 in every condition, and networks trained within G1020 were also close to chance. Strong in-domain results do not show that a glaucoma model will work on new data. Normalization and color augmentation reduce the drop but do not remove it. Studies should report external validation and check the operating threshold, not only AUC.

0.35

Deep learning of longitudinal visual fields predicts glaucoma progression rate and identifies fast progressors

cs.CV cs.AI ·2026-09-24 ·Taiabur Rahman, Siddiqur Rahman, Muhammad Moniruzzaman, Ummay Kawsar, Sayedatunnessa Ratna +5 more
hot direction similarity 0.64
Abstract

Glaucoma is the leading cause of irreversible blindness, and timely identification of fast progressors is essential to prevent disability. Current practice estimates progression by ordinary least-squares regression of mean deviation (MD) on time, requiring 6--10 visual field (VF) tests over several years to obtain a reliable slope. We present GLAM (Glaucoma Longitudinal Analysis Model), a deep learning framework that ingests longitudinal Humphrey 24-2 total deviation sequences with five clinical features and predicts MD and visual field index progression rates using attention-based fusion and aleatoric uncertainty. On the open-access University of Washington Humphrey Visual Field dataset (4,276 patient-eyes), GLAM achieved an MD-rate mean absolute error of 0.139 dB yr$^{-1}$ ($R^2 = 0.927$; 73.5% reduction over a ridge baseline) and an AUC of 0.990 for fast-progressor detection. VF-only deep learning can match multimodal pipelines for progression prognostication using routinely collected perimetry alone.

0.34

Attention-Enhanced Deep Features with Heterogeneous Ensemble Learning for Glaucoma Detection

cs.CV cs.AIcs.LG ·2026-09-06 ·Abdullah Al Shafi, Nishat Sadaf Lira, Abrar Hasan, Kazi Saeed Alam, Swapnil Kundu Argha
published similarity 0.61
Abstract · Accepted and presented at 2026 IEEE International Conference on Biomedical Engineering, Computer and Information Technology for Health (BECI…

Glaucoma is a progressive optic neuropathy characterized by irreversible damage to the optic nerve, making timely diagnosis critical to prevent permanent vision loss. Although deep learning has demonstrated promising performance in automated glaucoma detection, existing approaches often overlook feature refinement, suffer from class imbalance, and rely on individual classifiers that limit prediction robustness. To address these challenges, this paper proposes a hybrid glaucoma detection framework that integrates attention-enhanced deep feature extraction with heterogeneous ensemble learning. Specifically, deep representations are extracted using InceptionV3 and subsequently refined by incorporating the Convolutional Block Attention Module (CBAM) to enhance discriminative retinal features. To improve classification robustness, the extracted features are classified using multiple machine learning models together with Single-Level Ensemble (SLE) and Double-Level Ensemble (DLE) strategies, while SMOTE combined with Tomek Links (SMOTE+TL) is employed to alleviate class imbalance. Furthermore, a systematic comparison of handcrafted, deep, and attention-enhanced deep feature representations is conducted. Experimental evaluation on two public retinal fundus datasets demonstrates that deep feature-based methods consistently outperform handcrafted feature-based methods, while the proposed attention-enhanced framework achieves the best overall performance. Furthermore, Grad-CAM visualizations confirm that the proposed model focuses on clinically relevant retinal regions, providing interpretable evidence on the model's prediction process.

0.23

FOCUS: Benchmarking Retinal Model Generalization from Foundation Vision Encoders to Multimodal LLMs

cs.CV cs.AI ·2026-09-27 ·David Restrepo, Chenwei Wu, Luis Filipe Nakayama, Miguel L. Martins, Stergios Christodoulidis +2 more
top venuebenchmarkdatasetcode/data similarity 0.61
Abstract · Accepted at NeurIPS 2026, Evaluations & Datasets Track. Interactive benchmark dashboard: https://huggingface.co/spaces/dsrestrepo/FOCUS-Reti…

Progress in AI-based retinal image analysis has accelerated with the adoption of foundation models, yet evaluating their real-world reliability remains challenging. Performance reported on a single dataset does not capture how models behave under dataset shift, across clinical definitions, or for different patient subgroups. This limitation is particularly critical in medical imaging, where robustness, calibration, and fairness are essential for safe deployment. We introduce FOCUS (Foundation Ophthalmic Cross-Dataset Understanding under Shift), a cross-dataset benchmark evaluating retinal fundus models across vision-only encoder models (VM), vision-language dual-encoder models (VLM), and multimodal large language models (MLLM). FOCUS harmonizes binary diabetic retinopathy, referable diabetic retinopathy, and glaucomatous optic neuropathy tasks across ten public datasets spanning diverse geographies, acquisition conditions, and label protocols. The benchmark evaluates models through a unified analysis layer that measures ranking performance, calibration, subgroup disparities, and image-quality robustness. We present a large-scale evaluation covering 532 base configurations and 228 MLLM configurations adapted via LoRA fine-tuning. Results show no model family consistently dominates across tasks and datasets: general VM encoders achieve the strongest average ranking performance, medical MLLMs are competitive but variable, and dual-encoder VLMs benefit substantially from lightweight adaptation. Fine-tuning improves in-domain performance but exhibits heterogeneous transfer to external datasets, particularly in calibration. FOCUS provides a practical framework and public benchmark to assess generalization, reliability, and robustness beyond single-dataset leaderboards.

0.52